Order Article Reprints

Katopodi T, Petanidis S, Grigoriadou E, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G, Eskitzis P, Zarogoulidis P, Koulouris C, et al. Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy. Pharmaceutics. 2024; 16(4):455. https://doi.org/10.3390/pharmaceutics16040455

Katopodi, Theodora, Savvas Petanidis, Eirini Grigoriadou, Doxakis Anestakis, Charalampos Charalampidis, Ioanna Chatziprodromidou, George Floros, Panagiotis Eskitzis, Paul Zarogoulidis, Charilaos Koulouris, and et al. 2024. "Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy" Pharmaceutics 16, no. 4: 455. https://doi.org/10.3390/pharmaceutics16040455

Katopodi, T., Petanidis, S., Grigoriadou, E., Anestakis, D., Charalampidis, C., Chatziprodromidou, I., Floros, G., Eskitzis, P., Zarogoulidis, P., Koulouris, C., Sevva, C., Papadopoulos, K., Roulia, P., Mantalovas, S., Dagher, M., Karakousis, A. V., Varsamis, N., Vlassopoulos, K., Theodorou, V., ... Kosmidis, C. (2024). Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy. Pharmaceutics, 16(4), 455. https://doi.org/10.3390/pharmaceutics16040455